| Disease ID | Disease name | Reference |
|---|
| MESH:D000013 |
Congenital Abnormalities |
PMID:21237239; PMID:22633069; PMID:22736253 |
| MESH:D000077216 |
Carcinoma, Ovarian Epithelial |
PMID:23135907 |
| MESH:D000080874 |
Synucleinopathies |
PMID:34332006 |
| MESH:D000090862 |
Neuroinflammatory Diseases |
PMID:34332006; PMID:37364758 |
| MESH:D000230 |
Adenocarcinoma |
PMID:20127859; PMID:20464547 |
| MESH:D000236 |
Adenoma |
PMID:19841130; PMID:21562034; PMID:32062438; PMID:33939976; PMID:3802065; PMID:6695378; PMID:8571376; PMID:8761429; PMID:8912846 |
| MESH:D001005 |
Anus Neoplasms |
PMID:21863085 |
| MESH:D001145 |
Arrhythmias, Cardiac |
PMID:22209252 |
| MESH:D001161 |
Arteriosclerosis |
PMID:3142695 |
| MESH:D001249 |
Asthma |
PMID:28807506 |
| MESH:D001284 |
Atrophy |
PMID:31748929 |
| MESH:D001724 |
Birth Weight |
PMID:28233961 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
PMID:17053015; PMID:35764155 |
| MESH:D001919 |
Bradycardia |
PMID:21964300 |
| MESH:D001943 |
Breast Neoplasms |
PMID:17474063; PMID:20146248; PMID:26008800 |
| MESH:D002277 |
Carcinoma |
PMID:17060372 |
| MESH:D002278 |
Carcinoma in Situ |
PMID:25908611 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
PMID:20419170; PMID:21739481; PMID:22935520; PMID:25908611 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
PMID:11690565; PMID:16456883; PMID:18353537; PMID:21339737; PMID:21882252; PMID:22048643; PMID:22227536; PMID:22410783; PMID:23333640; PMID:23652152; PMID:24084393; PMID:24362009; PMID:25435355; PMID:25628927; PMID:27003318; PMID:27221058; PMID:28533128; PMID:31154059; PMID:32062438; PMID:32717239; PMID:32802178; PMID:3456598; PMID:6302407; PMID:6831639 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
PMID:21863085 |
| MESH:D002869 |
Chromosome Aberrations |
PMID:23333640; PMID:24120900; PMID:25374376; PMID:27235710; PMID:28233961 |
| MESH:D003072 |
Cognition Disorders |
PMID:34979192 |
| MESH:D003110 |
Colonic Neoplasms |
PMID:26271895 |
| MESH:D004195 |
Disease Models, Animal |
PMID:35038060; PMID:36736873 |
| MESH:D004487 |
Edema |
PMID:21964300 |
| MESH:D004938 |
Esophageal Neoplasms |
PMID:16530937; PMID:21863085 |
| MESH:D005234 |
Fatty Liver |
PMID:24107266; PMID:24291350; PMID:31730885 |
| MESH:D005317 |
Fetal Growth Retardation |
PMID:23656968; PMID:28233961 |
| MESH:D006330 |
Heart Defects, Congenital |
PMID:20471113; PMID:22209252; PMID:34597721 |
| MESH:D006331 |
Heart Diseases |
PMID:22374506; PMID:23656968 |
| MESH:D006332 |
Cardiomegaly |
PMID:21383588 |
| MESH:D006402 |
Hematologic Diseases |
PMID:35437857 |
| MESH:D006461 |
Hemolysis |
PMID:22052664 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
PMID:20501349 |
| MESH:D006529 |
Hepatomegaly |
PMID:32417428 |
| MESH:D006965 |
Hyperplasia |
PMID:18656336; PMID:25908611; PMID:26358852; PMID:33939976 |
| MESH:D006973 |
Hypertension |
PMID:37019984 |
| MESH:D006984 |
Hypertrophy |
PMID:18634860 |
| MESH:D007153 |
Immunologic Deficiency Syndromes |
PMID:8571374 |
| MESH:D007154 |
Immune System Diseases |
PMID:17934950; PMID:28233961 |
| MESH:D007247 |
Infertility, Female |
PMID:22342234 |
| MESH:D007249 |
Inflammation |
PMID:18656336; PMID:24657529; PMID:28032951 |
| MESH:D007414 |
Intestinal Neoplasms |
PMID:21863085 |
| MESH:D007674 |
Kidney Diseases |
PMID:11289703; PMID:21803694 |
| MESH:D007822 |
Laryngeal Neoplasms |
PMID:21863085 |
| MESH:D007859 |
Learning Disabilities |
PMID:20889680; PMID:21467743; PMID:21987461; PMID:22108330; PMID:23433211; PMID:23510837; PMID:25242404; PMID:28412278; PMID:32255272 |
| MESH:D008107 |
Liver Diseases |
PMID:17569222 |
| MESH:D008113 |
Liver Neoplasms |
PMID:20195826; PMID:21137059; PMID:21863085; PMID:3802065 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
PMID:2482284; PMID:3731386 |
| MESH:D008171 |
Lung Diseases |
PMID:31702096; PMID:37373040 |
| MESH:D008175 |
Lung Neoplasms |
PMID:15377764; PMID:17053015; PMID:18023135; PMID:18057710; PMID:18338764; PMID:18520028; PMID:18569708; PMID:18656336; PMID:18816296; PMID:19449198; PMID:20064080; PMID:20135361; PMID:20464547; PMID:20869020; PMID:21177068; PMID:21562034; PMID:21863085; PMID:22369883; PMID:25632966; PMID:26546711; PMID:28476633; PMID:28681665; PMID:30520250; PMID:30776357; PMID:32062438; PMID:33245929; PMID:33939976; PMID:34437932; PMID:34999049; PMID:36736873; PMID:3731386; PMID:3802065; PMID:6695378; PMID:8571376; PMID:8761429; PMID:8912846; PMID:9659573 |
| MESH:D008223 |
Lymphoma |
PMID:21863085 |
| MESH:D008569 |
Memory Disorders |
PMID:20889680; PMID:21467743; PMID:21839799; PMID:23433211; PMID:23510837; PMID:23684556; PMID:25242404; PMID:28412278; PMID:32255272 |
| MESH:D008654 |
Mesothelioma |
PMID:21863085 |
| MESH:D008679 |
Metaplasia |
PMID:26358852 |
| MESH:D009062 |
Mouth Neoplasms |
PMID:16381670 |
| MESH:D009336 |
Necrosis |
PMID:17961608; PMID:20719421; PMID:37364758 |
| MESH:D009361 |
Neoplasm Invasiveness |
PMID:24847786; PMID:25724548; PMID:29746904; PMID:30236600 |
| MESH:D009362 |
Neoplasm Metastasis |
PMID:25724548; PMID:29746904 |
| MESH:D009369 |
Neoplasms |
PMID:11141357; PMID:12174585; PMID:19216581; PMID:20206614; PMID:31702096; PMID:32062438 |
| MESH:D009374 |
Neoplasms, Experimental |
PMID:18057710; PMID:28681665; PMID:3037147; PMID:33044785; PMID:33939976; PMID:35487446; PMID:36736873; PMID:8912846 |
| MESH:D009410 |
Nerve Degeneration |
PMID:32255272; PMID:32619457 |
| MESH:D009421 |
Nervous System Malformations |
PMID:22265711 |
| MESH:D009436 |
Neural Tube Defects |
PMID:23656968 |
| MESH:D009669 |
Nose Neoplasms |
PMID:21863085 |
| MESH:D009845 |
Oligospermia |
PMID:22960446; PMID:27448386; PMID:37579952 |
| MESH:D010049 |
Ovarian Diseases |
PMID:28279692 |
| MESH:D010212 |
Papilloma |
PMID:17060372; PMID:22935520; PMID:25908611 |
| MESH:D010302 |
Parkinson Disease, Secondary |
PMID:34332006 |
| MESH:D010490 |
Pericardial Effusion |
PMID:26943738 |
| MESH:D010610 |
Pharyngeal Neoplasms |
PMID:21863085 |
| MESH:D010922 |
Placenta Diseases |
PMID:23656968 |
| MESH:D011230 |
Precancerous Conditions |
PMID:2578334; PMID:6288500 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
PMID:21803694; PMID:21987461; PMID:22253057; PMID:22374506; PMID:24107266; PMID:24291350; PMID:28279692; PMID:28329817; PMID:34332006; PMID:39967322 |
| MESH:D011471 |
Prostatic Neoplasms |
PMID:17292933 |
| MESH:D011596 |
Psychomotor Disorders |
PMID:23684556 |
| MESH:D012164 |
Retinal Diseases |
PMID:31748929 |
| MESH:D012509 |
Sarcoma |
PMID:21863085; PMID:21942922 |
| MESH:D012878 |
Skin Neoplasms |
PMID:10029692; PMID:17060372; PMID:19755658; PMID:21863085; PMID:22935520; PMID:24120900; PMID:25908611 |
| MESH:D013163 |
Splenomegaly |
PMID:26496743 |
| MESH:D013274 |
Stomach Neoplasms |
PMID:10874023; PMID:15527074; PMID:1618892; PMID:20155912; PMID:20737421; PMID:2093021; PMID:21863085; PMID:33663268; PMID:9310263 |
| MESH:D013733 |
Testicular Diseases |
PMID:31568845 |
| MESH:D014062 |
Tongue Neoplasms |
PMID:21863085 |
| MESH:D014591 |
Uterine Diseases |
PMID:26358852 |
| MESH:D015430 |
Weight Gain |
PMID:24107266; PMID:24291350; PMID:31730885; PMID:36736873 |
| MESH:D015431 |
Weight Loss |
PMID:18057710; PMID:26546711; PMID:28681665; PMID:30776357; PMID:31004597; PMID:31702096; PMID:35437857; PMID:39967322 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
PMID:21863085; PMID:21942922 |
| MESH:D016649 |
Primary Ovarian Insufficiency |
PMID:23135907; PMID:26247513 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
PMID:19183758 |
| MESH:D019283 |
Pancreatitis, Acute Necrotizing |
PMID:30165701 |
| MESH:D019457 |
Chromosome Breakage |
PMID:26809139; PMID:29502735 |
| MESH:D019636 |
Neurodegenerative Diseases |
PMID:28329817; PMID:34332006 |
| MESH:D019954 |
Neurobehavioral Manifestations |
PMID:16858674; PMID:22212102; PMID:31730894; PMID:39967322 |
| MESH:D020258 |
Neurotoxicity Syndromes |
PMID:21984485; PMID:23684556 |
| MESH:D020964 |
Embryo Loss |
PMID:35038060 |
| MESH:D024821 |
Metabolic Syndrome |
PMID:37019984 |
| MESH:D042822 |
Genomic Instability |
PMID:35690182 |
| MESH:D047928 |
Premature Birth |
PMID:26358852 |
| MESH:D048629 |
Micronuclei, Chromosome-Defective |
PMID:16242274; PMID:23639521; PMID:26603514; PMID:27913846; PMID:28233961; PMID:29154797; PMID:3037363; PMID:33961948; PMID:7556107 |
| MESH:D050197 |
Atherosclerosis |
PMID:22228805 |
| MESH:D051677 |
Histiocytoma, Malignant Fibrous |
PMID:2435491; PMID:3037147 |
| MESH:D053627 |
Asthenozoospermia |
PMID:27448386 |
| MESH:D053842 |
Microsatellite Instability |
PMID:19429261 |
| MESH:D055370 |
Lung Injury |
PMID:24657529; PMID:28681665; PMID:29019276; PMID:32061149; PMID:33393179; PMID:34027802; PMID:35437857 |
| MESH:D055371 |
Acute Lung Injury |
PMID:28032951 |
| MESH:D056486 |
Chemical and Drug Induced Liver Injury |
PMID:20719421; PMID:35378083; PMID:39111554 |
| MESH:D063646 |
Carcinogenesis |
PMID:28279692 |
| MESH:D064806 |
Dysbiosis |
PMID:33939976; PMID:39111554 |
| MESH:D065626 |
Non-alcoholic Fatty Liver Disease |
PMID:24291350 |
| MESH:D065886 |
Neurodevelopmental Disorders |
PMID:39967322 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.